Dr Elane Zelcer is a leader in the healthtech sector. She has significant experience advising and guiding research teams, start-up and early-stage companies and spin-outs in relation to commercialisation and capital raising, including risk management and governance.

Her focus is the intersection between the research sector and business. She uses her knowledge and experience to assist start-up/early-stage companies and their founders, as well as research-based organisations developing novel, value-add healthtech products.

Elane’s career spans director, scientific advisory board, executive management, management consulting, biotech and medtech start-up founder and research roles. She is a Director of AllergyPal Pty Ltd and BioMelbourne Network, venture partner with Access Capital Ventures, and a member of the Investment Committee for La Trobe University’s Breakthrough Victoria Eagle Fund.

Elane’s BSc (Hons), PhD & Grad Dip Mktg are from Monash University; she completed post-doctoral studies at McMaster University, Hamilton, Ontario, Canada and the University of Virginia, Charlottesville, Virginia, USA. In 2017 she was awarded Monash’s Faculty of Science Distinguished Alumni Award. She is a Fellow of the Australian Institute of Company Directors.